Table 3.
Strategy | Effect | Potential CO2e saving |
Where appropriate, switch from MDI to non-propellant inhaler | Avoids use of HFA propellants. | 8–36 kg per inhaler. |
Change from large volume reliever (eg, Ventolin Evohaler) to small volume reliever (eg, Salamol) | Small volume reliever contains far less propellant. | 18 kg per inhaler. |
Change from HFA227ea inhaler (eg, Flutiform or Symbicort MDI) to HFA134a inhaler | Uses lower GWP HFA propellant. | 20 kg CO2e per inhaler. |
Recycle used MDIs | The plastics and aluminium are recycled and the HFA gas is captured for re-use. | Estimated 4–18 kg per inhaler, although potentially risks further atmospheric release of HFA by delaying incineration. |
Return used inhalers to pharmacy after use | If the pharmacy cannot recycle the MDI, it will be incinerated. This causes thermal degradation of the HFA into chemicals with far smaller global warming potential.38 | Likely to be slightly lower than recycling due to the energy inputs for incineration, and the absence of recycled materials. Estimated 3–17 kg per inhaler. |
If there is no dose counter, ensure your patient knows how many doses the inhaler contains | Reduce waste from disposing of half-used inhalers. | Estimated to be a quarter of the inhaler’s carbon footprint; roughly 4 kg CO2e per inhaler. |
GWP, global warming potential; HFA, hydrofluoroalkane; HFA134a, 1,1,1,2-tetrafluoroethane; HFA227ea, 1,1,1,2,3,3,3-heptafluoropropane; MDI, metered-dose inhaler.